Israel China Biotechnology (ICB)

Overview

Silver Castle Holdings Ltd operates as a healthcare investment company, primarily focusing on the biomedical sector. Based in Tel Aviv, Israel, the company has been involved in strategically investing in companies within this vital industry since its establishment in 2000. Formerly known as Israel China Biotechnology (ICB) Ltd, the company rebranded to Silver Castle Holdings Ltd in February 2022 to better reflect its mission and objectives in the biotechnology investment landscape. With a strong commitment to improving healthcare solutions, Silver Castle endeavors to harness the potential of innovative biomedical technologies.

Products and Services

• Investment in Biomedical Companies

  Silver Castle Holdings Ltd invests capital in emerging and established companies within the biomedical field. These investments aim to foster innovation and growth in biotechnology, supporting the development of new therapies and medical technologies.

• Strategic Partnerships

  The company actively seeks partnerships with leading organizations and institutions in the biomedical sector in Israel. These alliances facilitate collaboration in research and development, enhancing the effectiveness of their investments.

• Market Analysis and Expertise

  Silver Castle provides detailed market analysis to inform its investment strategies. The company leverages its expertise in the biomedical field to assess the viability and potential of various healthcare technologies and market trends.

• Advisory Services

  In addition to direct investments, Silver Castle also offers advisory services to startups in the biomedical space, assisting them in navigating complex market dynamics and accelerating their growth potential.